Minutes of the Annual Assembly of Members, held on Tuesday 3 July 2018, 18.00 pm, at Centre de Convencions de Barcelona, Plaça de Willy Brandt 11-14, 08019 Barcelona, Spain
Cristine Magli, an investigator in the ESHRE-sponsored ESTEEM trial, explains more on the design of the study and why the results provide strong evidence about PGT-A.
Willem Verpoest, an IVF specialist at the VUB Brussels and co-ordinating investigator of the ESTEEM trial, considers the clinical benefits seen in this ESHRE-sponsored study of aneuploidy screening.
Australian andrologist John Aitken argues that two consequences of male ageing - declining fertility and passing on an ever increasing mutational load to offspring - are each a self-perpetuating function of oxidative stress.
For the first time, a large population study quantifies the effect of cancer and its treatment on the chances of pregnancy.
Karen Sermon, principal investigator of the ESTEEM trial, reviews the results and implications of this ESHRE-sponsored study of aneuploidy screening.
The Dutch gynaecologist Nils Lambalk will take over as editor-in-chief of Human Reproduction in January next year. He talks to Focus on Reproduction about his plans for the journal and the demands which editorship now implies.
Balancing the clinical benefits in miscarriage risk against the non-benefits in cumulative live birth rate.
ESTEEM trial co-ordinating investigator Willem Verpoest believes there are important benefits - and messages - to be found in this ESHRE study of aneuploidy screening
Bart Fauser, one of the principals behind the ESHRE/ASRM Rotterdam diagnostic consensus of 2003, on a new and fuller international guideline on PCOS launched in Barcelona.